Mpox clinical trials at UCSF

1 research study open to eligible people

Tecovirimat for Human Monkeypox Virus
open to all eligible people
A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.
San Francisco, California and other locations

Last updated: April 16, 2024